Is ProShares Ultra Nasdaq Biotechnology (BIB) a Buy, Sell, or Hold?
NASDAQ : BIB
ProShares Ultra Nasdaq Biotechnology — Competitors
$99.5 USD
$2.74 (2.83%)
- Volume
- 5.05K
- Average Volume
- 11.48K
- Market Capitalization
- $83.58M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $110.25
- Year Low
- $49.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
BIB vs. The Competition
| Properties | BIB | BKSE | CAMX | DIVL |
|---|---|---|---|---|
| Market Cap | $83.58M | $87.24M | $66M | $59.94M |
| Shares Outstanding | $839.98K | $1.96M | $1.9M | $2.41M |
| P/E Ratio | ||||
| EPS | ||||
| Day Low | 97.545 | 44.23 | 34.6861 | 24.735 |
| Day High | 99.83 | 44.52 | 34.8101 | 24.945 |
| Year Low | 49.24 | 33.00667 | 29.885 | 22.12 |
| Year High | 110.25 | 46.02334 | 35.191 | 25.602 |
| Average Price 50 | 89.246 | 42.98955 | 34.39274 | 24.67402 |
| Average Price 200 | 81.73505 | 39.68623 | 32.70962 | 24.04732 |
| Volume | 5050 | 26105 | 166 | 1565 |
| Average Volume | - | - | - | - |